4.27
                                            Schlusskurs vom Vortag:
              $4.15
            Offen:
              $4.15
            24-Stunden-Volumen:
                1.60M
            Relative Volume:
              1.08
            Marktkapitalisierung:
                $738.01M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-54.70M
            KGV:
              -12.94
            EPS:
                -0.33
            Netto-Cashflow:
                $-51.36M
            1W Leistung:
              -2.51%
            1M Leistung:
              +22.35%
            6M Leistung:
                +25.59%
            1J Leistung:
              +18.61%
            Savara Inc Stock (SVRA) Company Profile
Firmenname
                  
                      Savara Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      51285113796
                    
                Adresse
                  
                      6836 BEE CAVE ROAD, AUSTIN, TX
                    
                Vergleichen Sie SVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SVRA
                            
                             
                        Savara Inc 
                           | 
                    4.27 | 816.14M | 0 | -54.70M | -51.36M | -0.33 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight | 
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy | 
| 2025-05-29 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight | 
| 2024-11-13 | Herabstufung | Evercore ISI | Outperform → In-line | 
| 2024-02-15 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2023-11-07 | Eingeleitet | Guggenheim | Buy | 
| 2023-05-16 | Hochstufung | Jefferies | Hold → Buy | 
| 2023-03-31 | Herabstufung | Jefferies | Buy → Hold | 
| 2021-03-16 | Eingeleitet | Piper Sandler | Overweight | 
| 2021-03-15 | Eingeleitet | Oppenheimer | Outperform | 
| 2019-06-13 | Bestätigt | H.C. Wainwright | Buy | 
| 2019-06-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform | 
| 2019-06-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral | 
| 2018-08-13 | Fortgesetzt | ROTH Capital | Neutral | 
| 2018-01-03 | Eingeleitet | Ladenburg Thalmann | Buy | 
| 2017-09-27 | Fortgesetzt | ROTH Capital | Buy | 
| 2017-09-22 | Eingeleitet | Jefferies | Buy | 
| 2017-09-11 | Eingeleitet | JMP Securities | Mkt Outperform | 
                    Alle ansehen
                    
                  
                Savara Inc Aktie (SVRA) Neueste Nachrichten
Savara Hit with Class Action Over Molbreevi Misrepresentations - TipRanks
Latham & Watkins Advises RTW Investments in US$75 Million Royalty Funding Agreement With Savara - Legal Desire Media and Insights
Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class ActionContact Levi & Korsinsky - The Globe and Mail
Savara Announces Participation in Upcoming Investor Healthcare Conferences - The Joplin Globe
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - PR Newswire
Can Savara Inc. stock deliver surprise earnings beatJuly 2025 Trends & Real-Time Chart Breakout Alerts - newser.com
2025-11-02 | Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 | NDAQ:SVRA | Press Release - Stockhouse
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - PR Newswire
SVRA DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Savara Inc. Investors ... - Bluefield Daily Telegraph
SVRA DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Savara Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 7 Deadline in Securities Class Action– SVRA - GlobeNewswire Inc.
Class Action Filed Against Savara Inc. (SVRA) Over Securities ViolationsContact Levi & Korsinsky Today - Stockhouse
Why Savara Inc. stock could outperform in 2025Trade Signal Summary & Low Risk Entry Point Guides - newser.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
How strong dollar benefits Savara Inc. (YB4P) stockStop Loss & Capital Efficient Trade Techniques - newser.com
Investors SueWallSt Over Savara Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Savara completes $149.5 million public offering of common stock By Investing.com - Investing.com South Africa
Savara Closes $149.5 Million Public Offering - MarketScreener
Savara completes $149.5 million public offering of common stock - Investing.com
Savara (NASDAQ: SVRA) closes $149.5M offering priced at $4.20; option exercised - Stock Titan
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - The Joplin Globe
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss ... - Bluefield Daily Telegraph
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights – SVRA - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - Morningstar
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Savara Investors to ... - Bluefield Daily Telegraph
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
Is Savara Inc. (YB4P) stock in buy zone after pullbackStop Loss & Verified Short-Term Trading Plans - newser.com
Emerald Mutual Fund Advisers Trust Grows Position in Savara Inc. $SVRA - MarketBeat
Savara Inc. $SVRA Shares Purchased by Emerald Advisers LLC - MarketBeat
Pattern recognition hints at Savara Inc. upsideJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Visual analytics tools that track Savara Inc. performanceJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Chart overlay techniques for tracking Savara Inc.Market Performance Recap & Stock Timing and Entry Methods - newser.com
RTW Biotech Opportunities says Savara announces $75 million funding agreement with co - MarketScreener
Savara Announces $130 Million Public Offering - MSN
Will Savara Inc. (YB4P) stock boost dividends further2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
What Does Wall Street Think About Savara Inc. (SVRA)? - MSN
SVRA FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Savara Inc. Investors to ... - Caledonian Record
SVRA FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
Applying sector rotation models to Savara Inc.Quarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
SVRA sets underwritten deal; 30-day option for 4,642,857 shares - Stock Titan
Savara Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm ... - Bluefield Daily Telegraph
Savara Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
SVRA Deadline: Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders to Contact the Firm for Information About Their Rights - The AI Journal
Investors SueWallSt as Savara Inc. Faces Securities Fraud Allegations - Nasdaq
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - FinancialContent
Savara (NASDAQ:SVRA) Hits New 12-Month HighHere's Why - MarketBeat
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Quantum Corporation (QMCO), Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA) - GlobeNewswire
Finanzdaten der Savara Inc-Aktie (SVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):